Inflammation: Clinical Trials

38 trials for Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 unknown. 38 Phase 1, 27 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 138Unknown 38
Phase 227Unknown 27

Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation

Trials (filtered) newest first · largest first

All 38 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG
Normal saline, Dexmedetomidine, Methylprednisolone - Coronary Artery Disease, Systemic Inflammatory Response Syndrome
Phase 1 / Phase 2UnknownAin Shams University602025-09-012025-08-06
Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis
Imatinib, Compound sodium lactate solution - Sepsis, Fluid Overload
Phase 1 / Phase 2UnknownBelfast Health and Social Care Trust652024-12-012024-10-04
Beta-Hydroxybutyrate Feasibility Treating IBD
Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's - Crohn's Disease, Inflammatory Bowel Diseases
Phase 1 / Phase 2UnknownUniversity of Texas at Austin202024-08-282024-09-19
Effect of Quercetin in Treatment of Periodontitis
Quercetin, scaling and root planing - Inflammation Gum
Phase 1UnknownAssiut University202024-02-202024-01-31
Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air
0.070 ppm ozone concentration, Clean air (0.0 ppm ozone) - Lung Injury, Acute, Symptoms and Signs
Phase 1UnknownMartin W. Case602022-10-132023-01-11
KurCoSmart Effects on People With Type 2 DM
Curcumin and virgin coconut oil extract (KurCo Smart) - Diabetes Mellitus, Type 2, Insulin Resistance
Phase 1 / Phase 2UnknownUniversitas Sebelas Maret402022-06-012022-06-07
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock
Ondansetron, Placebo - Sepsis, Septic Shock
Phase 1 / Phase 2UnknownNoha Mansour402022-04-242023-03-15
Study for the Prevention of Oral Mucositis (SPOM)
Bocaliner, Benzydamine - Oral Mucositis
Phase 1 / Phase 2UnknownE2Bio Life Sciences, LLC1002022-04-152023-09-08
Colchicine Effect on Perivascular Inflammation Index on Coronary CTA
Colchicine - Atherosclerosis, Inflammatory Response
Phase 1UnknownUniversity of Sao Paulo General Hospital402022-03-072022-05-09
Anakinra for Preterm Infants Pilot
Anakinra - Prematurity; Extreme, Inflammation
Phase 1 / Phase 2UnknownMonash Medical Centre252022-02-152024-09-19
Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients
Albumin 20% and terlipressin - Septic Shock
Phase 1UnknownAmany Mousa Salama Muhammed362021-10-012021-10-15
High-dose Intravenous Vitamin C in Patients With Septic Shock
Sodium Ascorbate - Sepsis, Severe, Septic Shock
Phase 1UnknownMelbourne Health302021-09-272022-11-04
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
SBI-101 - COVID-19, Acute Kidney Injury
Phase 1 / Phase 2UnknownSentien Biotechnologies, Inc.222020-11-192022-01-14
Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)
Methotrexate-LDE phase 1, Methotrexate-LDE phase 2, Placebo-LDE phase 2 - Coronavirus, Inflammation
Phase 1 / Phase 2UnknownUniversity of Sao Paulo General Hospital1002020-10-272021-01-14
Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly.
Prolon - FMD - Frailty, Inflammation
Phase 1 / Phase 2UnknownUniversity of Genova402020-09-152021-10-25
Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
Drug: NA-831 - 0.10 mg/kg, Placebo- 0.10 mg/kg, Drug: NA-831 - 0.20 mg/kg - Covid19, Corona Virus Infection
Phase 1UnknownBiomed Industries, Inc.452020-09-152020-07-21
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
Collagen-Polyvinylpyrrolidone - Covid19, Cytokine Storm
Phase 1 / Phase 2UnknownJanette Furuzawa Carballeda902020-08-192021-02-17
LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab - COVID-19, Hospitalized COVID-19 Patients
Phase 1UnknownLebanese University10002020-03-282024-02-06
Biological Effects of Quercetin in COPD
Quercetin - Chronic Obstructive Pulmonary Disease
Phase 1 / Phase 2UnknownTemple University292019-10-012023-08-16
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
Metoprolol, metoprolol, infliximab, etanercept, tocilizumab and/or other agents - Solid Tumor, Hematological Malignancy
Phase 1 / Phase 2UnknownChinese PLA General Hospital302019-09-152022-04-13

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Sepsis (6)  ·  COVID-19 (5)  ·  Shock, Septic (4)  ·  Atherosclerosis (3)  ·  Acute Lung Injury (2)  ·  Carcinoma, Hepatocellular (2)  ·  Coronavirus Infections (2)  ·  Crohn Disease (2)  ·  Cytokine Release Syndrome (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Immune System Diseases (2)  ·  Insulin Resistance (2)  ·  Psychotic Disorders (2)  ·  Schizophrenia (2)

Broader conditions

Pathologic Processes (38)  ·  Pathological Conditions, Signs and Symptoms (38)  ·  Infections (13)  ·  Lung Diseases (12)  ·  Respiratory Tract Diseases (12)  ·  Systemic Inflammatory Response Syndrome (10)  ·  Shock (8)  ·  Digestive System Diseases (6)  ·  Coronaviridae Infections (5)  ·  Nidovirales Infections (5)  ·  Pneumonia, Viral (5)  ·  RNA Virus Infections (5)  ·  Respiratory Tract Infections (5)  ·  Signs and Symptoms (5)

Interventions

Saline Solution (3)  ·  Quercetin (2)  ·  remdesivir (2)  ·  tocilizumab (2)  ·  Albumins (1)  ·  Anti-Inflammatory Agents (1)  ·  Antiretroviral Therapy, Highly Active (1)  ·  Ascorbic Acid (1)  ·  Benzydamine (1)  ·  Budesonide (1)  ·  CHR 2845 (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Citrulline (1)  ·  Colchicine (1)  ·  Control Groups (1)

Sponsors

Ain Shams University (2)  ·  Brian Miller (2)  ·  Fast Forward Pharmaceuticals (2)  ·  Lebanese University (2)  ·  University of Sao Paulo General Hospital (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Amany Mousa Salama Muhammed (1)  ·  Assiut University (1)  ·  Belfast Health and Social Care Trust (1)  ·  Biomed Industries, Inc. (1)  ·  Chinese PLA General Hospital (1)  ·  E2Bio Life Sciences, LLC (1)  ·  Instituto Mexicano del Seguro Social (1)  ·  Janette Furuzawa Carballeda (1)  ·  Karolinska Institutet (1)

Countries

United States (8)  ·  China (4)  ·  Egypt (3)  ·  Netherlands (3)  ·  Australia (2)  ·  Brazil (2)  ·  Lebanon (2)  ·  Mexico (2)  ·  United Kingdom (2)  ·  Armenia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Indonesia (1)  ·  Italy (1)  ·  New Zealand (1)

Top investigators

Nehman Makdissy, Professor (2)  ·  Ahmed Mortada Fikry, professor (1)  ·  Andy Ghio, M.D. (1)  ·  Brian J Miller, MD (1)  ·  Claudia Nold, Prof (1)  ·  Daniel Azamar-Llamas, MD (1)  ·  David Propper (1)  ·  Eduardo Almeida Gutierrez, MSc (1)  ·  Eric Ochoa-Hein, MD (1)  ·  Erik S Stroes, MD PhD (1)

Results publications

PMID 10415784, PMID 12563677, PMID 14719037, PMID 15663512, PMID 16164444, PMID 17181919, PMID 17662768, PMID 18097874, PMID 19056593, PMID 19105791, PMID 19397687, PMID 19453649, PMID 19998041, PMID 20084502, PMID 20920189, PMID 21131395, PMID 22028728, PMID 22465313, PMID 22545014, PMID 22666356, PMID 22731679, PMID 23327349, PMID 23509945, PMID 23612995, PMID 23782971, PMID 26867177, PMID 28584818, PMID 29975735, PMID 30473697, PMID 31986264, PMID 32007143, PMID 32035018, PMID 32089354, PMID 32113509, PMID 32122636, PMID 32125455, PMID 32159775, PMID 32192578, PMID 32203186, PMID 32211963, PMID 32234467, PMID 32257537, PMID 32278362, PMID 32283152, PMID 32360286, PMID 32396163, PMID 32653469, PMID 33028396, PMID 36389766, PMID 37546740

NIH funding

2014 (1), 2015 (1), R33AT009991 (1)